ASH: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

(University of Pennsylvania School of Medicine) A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple myeloma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news